Actively Recruiting

Age: 0 - 18Years
All Genders
NCT06438965

MSOT as Non-invasive Biomarker for Diagnosis and Monitoring of Neuromuscular Diseases

Led by Children's Hospital of Eastern Ontario · Updated on 2025-02-12

240

Participants Needed

1

Research Sites

177 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The goal of this study is to learn if Multispectral Optoacoustic Tomographs (MSOT) works to diagnose and follow the course of neuromuscular diseases (NMDs) in children. MSOT scans will be obtained from muscle region to measure hemo/myoglobin, collagen and lipid content/signal and oxygenation in patients with neuromuscular diseases. No additional research activities -other than MSOT - will be done during this study. Existing clinical, laboratory and imaging data from standard-of-care procedures will be correlated with the MSOT data. The expected total duration of the study is approximately 36 months. Repeated measurements will be done to evaluate disease progression and the value of MSOT in NMD.

CONDITIONS

Official Title

MSOT as Non-invasive Biomarker for Diagnosis and Monitoring of Neuromuscular Diseases

Who Can Participate

Age: 0 - 18Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Patients with neuromuscular disease
  • Children from birth (infants born at term) to 18 years of age
  • Confirmed or suspected diagnosis of a neuromuscular disease through molecular genetics, biopsy, or clinical examination
Not Eligible

You will not qualify if you...

  • Diagnosis not consistent with confirmed or suspected neuromuscular disease
  • Active skin lesions such as infections or trauma
  • Confirmed genetic disorders that cause skin lesions (e.g., epidermolysis bullosa)
  • Medically unstable patients
  • Tattoos on skin over the area to be examined
  • Missing consent form
  • Any condition that compromises safety or data quality as judged by the investigator
  • Medication causing increased light sensitivity

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

CHEO

Ottawa, Ontario, Canada, K1H 8L1

Actively Recruiting

Loading map...

Research Team

H

Hanns Lochmuller, Dr.

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here